There were 818 press releases posted in the last 24 hours and 442,480 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ipsen fait le point sur la demande d’autorisation de mise sur le marché européen de Bylvay® pour traiter le prurit cholestatique chez les patients atteints du syndrome d'Alagille

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image